3,510
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) coverage among patients with chronic medical condition aged 50 and older

, , , &
Pages 1521-1528 | Received 02 Sep 2019, Accepted 04 Nov 2019, Published online: 04 Dec 2019

Figures & data

Table 1. Demographics and Health Characteristics of Japanese aged 50+ respondents with CMCs who vaccinated and unvaccinated the PPSV23 (n = 3,232).

Figure 1. Coverage rate of PPSV23 among those having CMCs in each age group (n = 3,232). CMC+: Chronic medical conditions, visiting hospital or clinic for treatment of following diseases: Chronic heart disease, Chronic lung disease, Diabetes mellitus, Chronic liver disease, Chronic renal disease, Cancer, etc.

Figure 1. Coverage rate of PPSV23 among those having CMCs in each age group (n = 3,232). CMC+: Chronic medical conditions, visiting hospital or clinic for treatment of following diseases: Chronic heart disease, Chronic lung disease, Diabetes mellitus, Chronic liver disease, Chronic renal disease, Cancer, etc.

Figure 2. Coverage rate of PPSV23 among each CMC groups and no-CMC group in aged 65+ (n = 1,712). CMC: Chronic medical conditions, visiting hospital or clinic for treatment of following diseases: Chronic heart disease, Diabetes mellitus, Cancer, Chronic lung disease, Chronic liver disease, Chronic renal disease.

Figure 2. Coverage rate of PPSV23 among each CMC groups and no-CMC group in aged 65+ (n = 1,712). CMC: Chronic medical conditions, visiting hospital or clinic for treatment of following diseases: Chronic heart disease, Diabetes mellitus, Cancer, Chronic lung disease, Chronic liver disease, Chronic renal disease.

Table 2. Factors associated with PPSV23 vaccination who those having CMCs in aged 65+.

Table 3. Factors associated with PPSV23 vaccination who those having CMCs in aged 50–59 and 60–64.

Figure 3. Recommendation of Pneumococcal vaccination to aged 50–64 and 65+ with CMC (Doctor: n = 399). CMC: Chronic medical conditions, visiting hospital or clinic for treatment of following diseases: Chronic heart disease, Chronic lung disease, Diabetes mellitus, Chronic liver disease, Chronic renal disease, Cancer, etc.

Figure 3. Recommendation of Pneumococcal vaccination to aged 50–64 and 65+ with CMC (Doctor: n = 399). CMC: Chronic medical conditions, visiting hospital or clinic for treatment of following diseases: Chronic heart disease, Chronic lung disease, Diabetes mellitus, Chronic liver disease, Chronic renal disease, Cancer, etc.
Supplemental material

Supplemental Material

Download MS Word (157.3 KB)